Fuji Pharma Co., Ltd.

TSE:4554.T

1611 (JPY) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q42011 Q32011 Q22011 Q12010 Q42010 Q32010 Q22010 Q12009 Q42009 Q32009 Q22009 Q1
Revenue 11,76710,64210,74611,40710,2579,2299,9968,9568,7448,2809,4468,4928,2217,9829,2958,8947,9947,9378,9688,9558,8418,20410,27910,0379,9118,0049,9579,3718,6928,3928,9329,2018,1927,9098,9278,6807,5407,3938,0678,2546,7837,2746,9047,1486,0306,0185,9786,107.7625,634.6674,927.2664,852.375,857.4035,021.0935,257.6685,487.6474,979.4815,155.4044,342.9595,224.1115,130.1524,489.483,673.4553,908.148
Cost of Revenue 7,4886,0457,1936,4186,3555,6395,9625,5495,2684,6095,4414,8684,7584,3535,2604,9994,6674,3544,9015,0954,8274,7825,7795,9775,9404,6665,3765,4834,9994,9495,2405,6334,9734,6545,4315,2254,4454,2074,8324,7064,0034,2113,9153,9983,4833,4753,2773,411.293,281.0062,816.2422,695.4383,059.2122,520.7382,792.4492,951.4222,633.7182,863.2892,268.122,857.4382,718.0532,494.9932,028.3212,164.415
Gross Profit 4,2794,5973,5534,9893,9023,5904,0343,4073,4763,6714,0053,6243,4633,6294,0353,8953,3273,5834,0673,8604,0143,4224,5004,0603,9713,3384,5813,8883,6933,4433,6923,5683,2193,2553,4963,4553,0953,1863,2353,5482,7803,0632,9893,1502,5472,5432,7012,696.4722,353.6612,111.0242,156.9322,798.1912,500.3552,465.2192,536.2252,345.7632,292.1152,074.8392,366.6732,412.0991,994.4871,645.1341,743.733
Gross Profit Ratio 0.3640.4320.3310.4370.380.3890.4040.380.3980.4430.4240.4270.4210.4550.4340.4380.4160.4510.4540.4310.4540.4170.4380.4050.4010.4170.460.4150.4250.410.4130.3880.3930.4120.3920.3980.410.4310.4010.430.410.4210.4330.4410.4220.4230.4520.4410.4180.4280.4450.4780.4980.4690.4620.4710.4450.4780.4530.470.4440.4480.446
Reseach & Development Expenses 05891,1379228946986707615725905621,04354254703,0600002,0520001,7600001,8250001,8400001,7290001,7690001,2800000000000000000000
General & Administrative Expenses 000000000001,418000-784000-1,141000-1,107000-944000-956000-1,332000-968000-6780000000000000000000
Selling & Marketing Expenses 000000000001,3450001,4890001,8880001,8190001,5370001,2570001,4060001,1250001,0380000000000000000000
SG&A 3,5072,4242,4722,5312,3512,1792,0951,7501,9321,8611,8122,7631,9372,0242,3367052,8392,9013,0137472,7562,5602,8947122,6982,7892,8555932,4072,4422,4173012,1842,2702,661742,3202,5662,4151572,1272,3312,1593601,9431,7931,8410000000000000000
Other Expenses 0-7618349152,9562,8433,2382,5762,521-111-1344-25483561631955-3228711456-1161725151872471,7931,84112.2567.1070.8334.065-10.8114.2351.4532.1342.1263.8370.0052.4092.4732.0884.9031.711
Operating Expenses 3,5073,0133,6923,5293,3242,9562,8433,2382,5762,5212,4423,8722,5492,6412,3362,9752,8392,9013,0133,4082,7562,5602,8943,2132,6982,7892,8553,1312,4072,4422,4172,8492,1842,2702,6612,4142,3202,5662,4152,5862,1272,3312,1592,0981,9431,7931,841912.9091,616.8081,598.31,695.0811,047.8431,595.8731,733.8971,583.066891.9571,419.3731,407.5641,423.606839.8591,389.2661,246.6991,198.703
Operating Income 7721,584-1401,4555796349084529001,1501,562-2519149881,6989164886821,0534471,2598621,6058441,2725501,7257531,2871,0001,2747151,0349858341,0387736218199596537328291,0486047508591,783.563736.853512.724461.8511,750.348904.482731.322953.1591,453.806872.742667.275943.0671,572.24605.221398.435545.03
Operating Income Ratio 0.0660.149-0.0130.1280.0560.0690.0910.050.1030.1390.165-0.030.1110.1240.1830.1030.0610.0860.1170.050.1420.1050.1560.0840.1280.0690.1730.080.1480.1190.1430.0780.1260.1250.0930.120.1030.0840.1020.1160.0960.1010.120.1470.10.1250.1440.2920.1310.1040.0950.2990.180.1390.1740.2920.1690.1540.1810.3060.1350.1080.139
Total Other Income Expenses Net 205883,996203-294243389-2686113419-115-48-2187-1371,228-1,34533-183-61105-7370-74-17102-44013247-37-164-23314-156-351827-39118782-5113107-805.9773.045-4.367-361.849-813.532-5.091-13.786-10.043-752.385-8.653-18.852-0.781-615.1552.219.901-58.495
Income Before Tax 7922,1713,8561,6582858771,579-1039611,2841,581-3668669861,8857791,716-6631,0862641,1989671,5329141,1985331,8277091,2871,0131,5216788707528488827386398469206547519071,049553762968977.586739.898508.357100.002936.816899.391717.536943.116701.421864.089648.423942.286957.085607.421418.336486.535
Income Before Tax Ratio 0.0670.2040.3590.1450.0280.0950.158-0.0120.110.1550.167-0.0430.1050.1240.2030.0880.215-0.0840.1210.0290.1360.1180.1490.0910.1210.0670.1830.0760.1480.1210.170.0740.1060.0950.0950.1020.0980.0860.1050.1110.0960.1030.1310.1470.0920.1270.1620.160.1310.1030.0210.160.1790.1360.1720.1410.1680.1490.180.1870.1350.1140.124
Income Tax Expense 1396541,11620575219464-157153568462-157246293556259461-228340-1773723674361483359152596387302443225277224303193205284330293205291364407215287355399.386260.662176.969117.895335.133336.157239.575381.148243.333349.218247.839371.757353.012232.615156.81200.982
Net Income 6531,5182,7391,4532106581,114548087161,118-2096206931,3285201,255-4357454418265991,0967668634421,3016138997121,077453593527545689532355516627449459543643337476612578.2479.235331.387-17.892601.683563.234477.961561.968458.088514.871400.583570.528604.073374.806261.525285.553
Net Income Ratio 0.0550.1430.2550.1270.020.0710.1110.0060.0920.0860.118-0.0250.0750.0870.1430.0580.157-0.0550.0830.0490.0930.0730.1070.0760.0870.0550.1310.0650.1030.0850.1210.0490.0720.0670.0610.0790.0710.0480.0640.0760.0660.0630.0790.090.0560.0790.1020.0950.0850.067-0.0040.1030.1120.0910.1020.0920.10.0920.1090.1180.0830.0710.073
EPS 26.8662.44112.6959.798.6427.0845.851.4822.1519.6346.05-6.7119.922.2442.6416.6940.28-13.9623.9214.1626.5120.0236.6325.628.8414.7743.4820.4830.0323.836.0315.1419.8217.6218.2323.0417.7911.3616.5220.0614.3716.2519.2622.7711.9316.8621.7120.4816.9711.73-0.6323.3821.8818.5721.8317.820.0115.5722.1723.4714.5610.1611.09
EPS Diluted 26.8662.44112.6959.798.6427.0845.851.4822.1519.6346.05-6.7119.922.2442.6416.6940.28-13.9623.9214.1626.5120.0236.6325.628.8414.7743.4820.4830.0323.836.0315.1419.8217.6218.2323.0417.7911.3616.5220.0614.3716.2519.2622.7711.9316.8621.7120.4816.9711.73-0.6323.3821.8818.5721.8317.820.0115.5722.1723.4714.5610.1611.09
EBITDA 1,527.752,2144,7412,4811,0911,6462,3276641,7351,9392,2072331,2931,5882,4161,3112,251-1381,5898081,820.751,396.52,0789231,2075431,8377181,2951,0161,5356878737678568917476488569336657649191,0615697819761,286.2951,042.967816.513766.0752,036.1581,165.271964.1311,179.2571,724.4071,143.615927.3591,175.2211,837.453853.254645.328766.114
EBITDA Ratio 0.130.2310.0650.1420.0610.0760.1320.0230.1110.1580.17-0.0390.1070.1270.1870.0950.0690.0670.1220.0520.1390.1090.1470.0920.1220.0680.1840.0870.1490.1210.1720.0760.1020.1130.0960.1030.0990.0860.1060.1130.0980.1050.1330.1480.1020.130.1630.3330.1860.1660.1580.3480.2320.1830.2150.3460.2220.2140.2260.3580.190.1720.196